The effects of the phosphodiesterase inhibitor olprinone on global cerebral ischemia

Anesthesia and Analgesia

Volumn 110, Issue 3, 2010, Pages 888-894

  Okayama, Naoko ^a   Matsunaga, Akira ^a   Kakihana, Yasuyuki ^a   Fujikawa, Kohsho ^a   Inoue, Kazuhiko ^a   Nagayama, Tetsuya ^a   Takeyama, Masaharu ^a   Miyata, Atsuro ^a   Kanmura, Yuichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOSE; LOPRINONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL COUNT; CELL HYPOXIA; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; MALE; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION;

EID: 77949276393     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181cb5cdd     Document Type: Article

References (31)

1. Tanio H, Kumada T, Hayashi M, Himura Y, Nakamura Y, Kawai C. Hemodynamic efficacy of E-1020 in comparison with dopamine on acute mitral regurgitation in anesthetized dogs. Jpn Circ J 1991; 55: 1068-1076
2. Tanoue Y, Morita S, Nagano I, Ochiai Y, Tominaga R, Kawachi Y, Yasui H. Effect of phosphodiesterase III inhibitor on contractility, afterload, and vascular capacitance during right heart bypass preparation. Jpn J Thorac Cardiovasc Surg 2001; 49: 607-613
3. Yu Y, Mizushige K, Ueda T, Nishiyama Y, Seki M, Aoyama T, Ohkawa M, Matsuo H. Effect of olprinone, phosphodiesterase III inhibitor, on cerebral blood flow assessed with technetium99m-ECD SPECT. J Cardiovasc Pharmacol 2000; 35: 422-426 (Pubitemid 30127190)
4. SundgreenC,LarsenFS,HerzogTM,KnudsenGM,BoesgaardS,AldershvileJ. Autoregulationofcerebralbloodflowinpatientsresuscitatedfromcardiacarrest. Stroke2001;32:128-132(Pubitemid32063836)
5. Choi JM, Shin HK, Kim KY, Lee JH, Hong KW. Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats. J Pharmacol Exp Ther 2002; 300: 787-793
6. Lee JH, Lee YK, Ishikawa M, Koga K, Fukunaga M, Miyakoda G, Mori T, Hosokawa T, Hong KW. Cilostazol reduces brain lesion induced by focal cerebral ischemia in rats-an MRI study. Brain Res 2003; 994: 91-98 (Pubitemid 37452441)
7. Lee JH, Kim KY, Lee YK, Park SY, Kim CD, Lee WS, Rhim BY, Hong KW. Cilostazol prevents focal cerebral ischemic injury by enhancing casein kinase 2 phosphorylation and suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation in rats. J Pharmacol Exp Ther 2004; 308: 896-903
8. Watanabe T, Zhang N, Liu M, Tanaka R, Mizuno Y, Urabe T. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Stroke 2006; 37: 1539-1545 (Pubitemid 44305739)
9. MabuchiT,KitagawaK,KuwabaraK,TakasawaK,OhtsukiT,XiaZ,StormD,YanagiharaT, HoriM,MatsumotoM.PhosphorylationofcAMPresponseelement- bindingproteininhippocampalneuronsasaprotectiveresponseafterexposure- glutamateinvitroandischemiainvivo.JNeurosci2001;21:9204-9213(Pubitemid33096864)
10. Meiler R, Minami M, Cameron JA, Impey S, Chen D, Lan JQ, Henshall DC, Simon RP. CREB-mediated Bcl-2 protein expression after ischemic preconditioning. J Cereb Blood Flow Metab 2005; 25: 234-246 (Pubitemid 40171205)
11. Pulsinelli WA, Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 1979; 10: 267-272
12. Bachis A, Major EO, Mocchetti I. Brain-derived neurotrophic factor inhibits human immunodeficiency virus-l/gp120mediated cerebellar granule cell death by preventing gp120 internalization J Neurosci 2003; 23: 5715-5722
13. BlockF,TondarA,SchmidtW,SchwarzM. Delayedtreatmentwithrolipramprotectsagainstneuronaldamagefollowingglobalischemi ainrats.Neuroreport1997;8:3829-3832(Pubitemid28004883)
14. Kato H, Araki T, Itoyama Y, Kogure K. Rolipram, a cyclic AMP-selective phosphodiesterase inhibitor, reduces neuronal damage following cerebral ischemia in the gerbil. Eur J Pharmacol 1995; 272: 107-110
15. MizushigeK,UedaT,YukiiriK,SuzukiH.Olprinone: aphosphodiesteraseIIIinhibitorwithpositiveinotropicandvasodilatoreffects. CardiovascDrugRev2002;20:163-174(Pubitemid35204766)
16. Murakami R, Sano K, Murakami Y, Shimada T, Morioka S. Effects of intracoronary infusion of an inotropic agent, E-1020 (loprinone hydrochloride), on cardiac function: evaluation of left ventricular contractile performance using the end-systolic pressure-volume relationship. Int J Cardiol 1995;51:57-63 17.
17. Sato K, Yoshimoto A. Effects of olprinone on systemic and cerebral circulation in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol 2000; 12: 81-83
18. Nikulina E, Tidwell JL, Dai HN, Bregman BS, Filbin MT. The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc Natl Acad Sci USA 2004; 101: 8786-8790 (Pubitemid 38745849)
19. Tosaka S, Makita T, Tosaka R, Maekawa T, Cho S, Hara T, Ureshino H, Sumikawa K. Cardioprotection induced by olprinone, a phosphodiesterase III inhibitor, involves phosphatidylinositol-3-OH kinase-Akt and a mitochondrial permeability transition pore during early reperfusion. J Anesth 2007; 21: 176-180 (Pubitemid 46692010)
20. Mizutani A, Murakami K, Okajima K, Kira S, Mizutani S, Kudo K, Takatani J, Goto K, Hattori S, Noguchi T. Olprinone reduces ischemia/reperfusion-induced acute renal injury in rats through enhancement of cAMP. Shock 2005; 24: 281-287 (Pubitemid 41279494)
21. Sasaki T, Kitagawa K, Omura-Matsuoka E, Todo K, Terasaki Y, Sugiura S, Hatazawa J, Yagita Y, Hori M. The phosphodiesterase inhibitor rolipram promotes survival of newborn hippocampal neurons after ischemia. Stroke 2007; 38: 1597-1605 (Pubitemid 46684180)
22. Hara T, Hamada J, Yano S, Morioka M, Kai Y, Ushio Y. CREB is required for acquisition of ischemic tolerance in gerbil hippocampal CAl region. J Neurochem 2003; 86: 805-814 (Pubitemid 36988793)
23. Lee HT, Chang YC, Wang LY, Wang ST, Huang CC, Ho CJ. cAMP response element-binding protein activation in ligation preconditioning in neonatal brain. Ann Neurol 2004; 56: 611-623 (Pubitemid 39540741)
24. Koike T, Nadeen Qutab M, Tsuchida M, Takekubo M, Saito M, Hayashi J. Pretreatment with olprinone hydrochloride, a phosphodiesterase III inhibitor, attenuates lipopolysaccharideinduced lung injury via an anti-inflammatory effect. PuIm Pharmacol Ther 2008; 21: 166-171
25. Miyakawa H, Kira S, Okuda K, Takeshima N, Mori M, Noguchi T. Olprinone decreases elevated concentrations of cytokine-induced neutrophil chemoattractant-1 in septic rats. J Anesth 2008; 22: 27-31 (Pubitemid 351338771)
26. Schneider A, Böttiger BW, Popp E. Cerebral resuscitation after cardiocirculatory arrest. Anesth Analg 2009;108: 971-979
27. Froehler MT, Geocadin RG. Hypothermia for neuroprotection after cardiac arrest: mechanisms, clinical trials and patient care. J Neurol Sci 200715; 261: 118-126
28. Kern KB, Hilwig RW, Rhee KH, Berg RA. Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol 1996; 28: 232-240
29. Laurent I, Monchi M, Chiche JD, Joly LM, Spaulding C, Bourgeois B, Cariou A, Rozenberg A, Carli P, Weber S, Dhainaut JF. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 2002; 40: 2110-2116 (Pubitemid 36005895)
30. Ueda T, Mizushige K, Yukiiri K, Takahashi T, Kohno M. Improvement of cerebral blood flow by olprinone, a phosphodiesterase-3 inhibitor, in mild heart failure. Cerebrovasc Dis 2003; 16: 396-401 (Pubitemid 37140430)
31. Yukiiri K, Mizushige K, Ueda T, Nishiyama Y, Aoyama T, Kohno M. Effects of olprinone, a phosphodiesterase 3 inhibitor, on regional cerebral blood flow of cerebral cortex in stroke patients. J Cardiovasc Pharmacol 2001; 37: 375-380 (Pubitemid 32240419)